CurrentCardio
Get Weekly

Topic · page 8 of 21

Prevention & lipids

Lipids, Lp(a), lifestyle (activity, diet, alcohol, smoking), risk scores, primary prevention in general or older populations, frailty and CV risk

Briefs 281–320 of 838 placed here, newest publication first

Briefs in Prevention & lipids

Newest publication first

  1. J Am Coll Cardiol

    Impact of Long-Term Cumulative Exposure to Wildfire Smoke PM2.5 on Cardiovascular Hospital Admissions Among Older Adults in the United States: A Population-Based Cohort Study

    Cohort study

  2. Eur J Prev Cardiol

    Normalized creatinine-to-cystatin C ratio and atherosclerotic cardiovascular disease risk in the UK Biobank

    Cohort study

  3. Circ Popul Health Outcomes

    Coronary Artery Calcium Progression and Cognitive Function in Midlife—The Coronary Artery Risk Development in Young Adults (CARDIA) Study

    Cohort study

  4. Eur J Prev Cardiol

    Effect of bempedoic acid on cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease

    Secondary analysis

  5. Eur J Prev Cardiol

    Low-density lipoprotein cholesterol, coronary plaque burden, and myocardial infarction in adults aged 76–92 years: the Western Denmark Heart Registry

    Cohort study

  6. Eur Heart J

    Lipoprotein(a)-lowering therapies: a promising future

    Research article

  7. J Am Coll Cardiol

    Effect of Low-Carbohydrate and Low-Fat Diets on Metabolomic Indices and Coronary Heart Disease in U.S. Individuals

    Cohort study

  8. Circulation

    Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, and Tools for Risk of Cardiovascular Disease: A Scientific Statement From the American Heart Association

    Guideline or statement

  9. Eur Heart J

    Wine consumption, Mediterranean diet, and cardiovascular risk in two Spanish cohorts

    Cohort study

  10. Circulation

    Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association

    Guideline or statement

  11. Eur Heart J Qual Care Clin Outcomes

    Sustainable and effective lipid-lowering management: prevention strategies from the BRING-UP prevention study

    Cohort study

  12. N Engl J Med

    A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide

    Randomised controlled trial

  13. J Am Coll Cardiol

    PREVENT Equations in Young Adults: Fairness, Calibration, and Performance Across Racial and Ethnic Groups

    Cohort study

  14. Resuscitation

    Frailty and one year survival in patients admitted to the intensive care unit following a medical emergency team review: a retrospective registry-based study

    Cohort study

  15. JAMA Cardiol

    Anti-ANGPTL3 Antibody SHR-1918 for Homozygous Familial Hypercholesterolemia: A Nonrandomized Clinical Trial

    Research article

  16. JAMA Cardiol

    Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a)

    Cohort study

  17. Eur J Prev Cardiol

    Economic evaluation of alternative cardiac rehabilitation programmes compared to centre-based cardiac rehabilitation programmes: a systematic review

    Meta-analysis

  18. Eur J Prev Cardiol

    Long-term adherence to the new Nordic Nutrition Recommendations in relation to cardiovascular events and cardiometabolic biomarkers

    Cohort study

  19. Eur Heart J

    Peripheral autonomic dysregulation in response to standing: a new form associated with cardiovascular disease, mobility reduction, and cognitive alterations

    Cohort study

  20. JACC Adv

    Prehabilitation in Patients Undergoing Cardiac Procedures: A Systematic Review and Meta-Analysis

    Meta-analysis

  21. JACC Adv

    Automated Abdominal Aortic Calcification Scores and Atherosclerotic Cardiovascular Disease in the UK Biobank Imaging Study

    Diagnostic or prognostic study

  22. Eur Heart J Cardiovasc Imaging

    Lipoprotein(a) selectively associates with vulnerable coronary plaque phenotypes in comparison with other established risk markers

    Research article

  23. Eur J Prev Cardiol

    Refined physical activity recommendations considering cardiovascular disease risk stratification: a cohort study

    Cohort study

  24. JACC Adv

    Association of Objective Physical Activity and Mortality in American Heart Association’s Life’s Essential 8

    Cross-sectional study

  25. Am Heart J

    Low levels of atherogenic lipoproteins and incident atherosclerotic cardiovascular disease: A pooled cohort primary prevention study

    Cohort study

  26. Eur Heart J Qual Care Clin Outcomes

    Validation of the European SCORE2 algorithm in one European and one Latin-American cohort studies with contrasting populations

    Diagnostic or prognostic study

  27. JACC Adv

    Hormone Replacement Therapy and Cardiovascular Outcomes by Race and Ethnicity: MESA (Multi-Ethnic Study of Atherosclerosis)

    Cohort study

  28. Eur J Prev Cardiol

    Cardiovascular disease averted by China’s Clean Air Act and the potential benefit of further air pollution intervention: evidence based on the parametric G-computation

    Cohort study

  29. JACC Adv

    U-Shaped Lipid-CVD Links in Older Adults: Reversed LDL-C and HDL-C Associations and Goldilocks Zone

    Research article

  30. Circ Popul Health Outcomes

    Workplace Racial Segregation, Job Mobility, and Cardiovascular Disease Mortality Among Black US Autoworkers

    Cohort study

  31. Eur Heart J

    Risk-weighted apoB: a novel summary metric outperforming traditional lipid biomarkers in predicting coronary heart disease

    Diagnostic or prognostic study

  32. JACC Adv

    Shifting Thresholds: Changes in Antihypertensive Eligibility Under the 2025 Versus 2017 Hypertension Guidelines

    Cross-sectional study

  33. Circulation

    2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

    Guideline or statement

  34. JACC Adv

    Potential Eligibility and Estimated Preventable Cardiovascular Disease Events From Inclisiran Treatment in the United States

    Cross-sectional study

  35. J Am Coll Cardiol

    Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A Statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federation

    Research article

  36. JACC Adv

    Healthy Sleep Patterns, Mortality, and Life Expectancy in Adults With and Without Atherosclerotic Cardiovascular Disease

    Research article

  37. Eur J Prev Cardiol

    The additive prognostic value of lipoprotein(a) for all-cause and cardiovascular mortality across the traditional cardiovascular risk continuum: analysis from NHANES III (1988–1994) with follow-up to 2019

    Cohort study

  38. JAMA

    Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial

    Randomised controlled trial

  39. Eur J Prev Cardiol

    Estimation of lifetime benefits from the optimization of secondary prevention in patients with established atherosclerotic cardiovascular disease

    Research article

  40. JAMA

    Familial Hypercholesterolemia Screening in Childhood and Early Adulthood: A Cost-Effectiveness Study

    Cohort study

All 838 Briefs in ExploreShowing Briefs 281–320 of 838, newest first